González Martín, A., Desauw, C., Heitz, F., Cropet, C., Gargiulo, P., Berger, R., . . . Ray-Coquard, I. (2022). Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial. European journal of cancer, 174, . https://doi.org/10.1016/j.ejca.2022.07.022
Chicago-Zitierstil (17. Ausg.)González Martín, Antonio, et al. "Maintenance Olaparib Plus Bevacizumab in Patients with Newly Diagnosed Advanced High-grade Ovarian Cancer: Main Analysis of Second Progression-free Survival in the Phase III PAOLA-1/ENGOT-ov25 Trial." European Journal of Cancer 174 (2022). https://doi.org/10.1016/j.ejca.2022.07.022.
MLA-Zitierstil (9. Ausg.)González Martín, Antonio, et al. "Maintenance Olaparib Plus Bevacizumab in Patients with Newly Diagnosed Advanced High-grade Ovarian Cancer: Main Analysis of Second Progression-free Survival in the Phase III PAOLA-1/ENGOT-ov25 Trial." European Journal of Cancer, vol. 174, 2022, https://doi.org/10.1016/j.ejca.2022.07.022.